MaxCyte (MXCT) Financial Statements

75 Followers

MaxCyte Financial Overview

MaxCyte's market cap is currently $90.32M. The company's EPS TTM is $-0.09; its P/E ratio is -4.30; MaxCyte is scheduled to report earnings on March 24, 2026, and the estimated EPS forecast is $-0.08. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	$ 33.03M	$ 38.63M	$ 41.29M	$ 44.26M	$ 33.89M
Gross Profit	$ 22.58M	$ 31.53M	$ 36.55M	$ 39.16M	$ 30.25M
Operating Income	$ -43.55M	$ -51.20M	$ -48.30M	$ -27.36M	$ -18.19M
EBITDA	$ -38.40M	$ -46.41M	$ -44.13M	$ -24.66M	$ -16.61M
Net Income	$ -44.63M	$ -41.05M	$ -37.92M	$ -23.57M	$ -19.08M
Balance Sheet
Cash & Short-Term Investments	$ 103.04M	$ 154.48M	$ 168.29M	$ 227.34M	$ 255.04M
Total Assets	$ 202.51M	$ 239.47M	$ 268.27M	$ 286.65M	$ 284.12M
Total Debt	$ 17.94M	$ 18.03M	$ 18.74M	$ 16.09M	$ 5.68M
Net Debt	$ -2.12M	$ -9.85M	$ -27.76M	$ 5.03M	$ -42.10M
Total Liabilities	$ 31.02M	$ 33.22M	$ 36.11M	$ 32.69M	$ 21.22M
Stockholders' Equity	$ 171.49M	$ 206.25M	$ 232.17M	$ 253.97M	$ 262.90M
Cash Flow
Free Cash Flow	$ -36.18M	$ -29.26M	$ -25.39M	$ -33.26M	$ -14.51M
Operating Cash Flow	$ -34.41M	$ -27.61M	$ -21.69M	$ -14.78M	$ -10.68M
Investing Cash Flow	$ 25.93M	$ 6.93M	$ 54.98M	$ -24.82M	$ -195.01M
Financing Cash Flow	$ 656.00K	$ 2.06M	$ 2.14M	$ 2.89M	$ 234.72M

Currency in USD

MaxCyte Earnings and Revenue History

Income Statement >

MaxCyte Debt to Assets

Balance Sheet >

MaxCyte Cash Flow

Cash Flow >

MaxCyte Forecast EPS vs Actual EPS

Earnings >